---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-011798"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2024-03-07T23:59:59+00:00"
generated_at: "2026-06-05T01:21:43.117974+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sanuwave Health licenses intravascular shockwave patents for $2.5M; extends debt forbearance to April 30, 2024

## Summary
- Licensed intravascular shockwave patent portfolio to Vascular Wave LLC for $2.5M upfront; option to acquire for additional single-digit millions.
- Noteholders consented to the license and waived related defaults; forbearance on existing defaults continued until April 30, 2024.
- Patents released from NPA collateral; default rate interest continues to accrue during forbearance.
- Company remains in default but avoids immediate enforcement; must still comply with all other obligations under NPA.

## SEC filing metadata
- accession: 0001140361-24-011798
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2024-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000114036124011798/0001140361-24-011798-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000114036124011798/ef20023331_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-011798
- JSON: https://secwatch.observer/filing/0001140361-24-011798.json
- Plain text: https://secwatch.observer/filing/0001140361-24-011798.txt

## Key facts
- Material Agreements
  SANUWAVE Health, Inc. amended Consent, Limited Waiver and Fifth Amendment to Note and Warrant Purchase Agreement with NH Expansion Credit Fund Holdings LP (effective 2024-03-06).
  - Action: amendment
  - Counterparty: NH Expansion Credit Fund Holdings LP
  - Effective: 2024-03-06
  source text: On March 6, 2024, Sanuwave Health, Inc. (the “Company”) entered into a Consent, Limited Waiver and Fifth Amendment to Note and Warrant Purchase Agreement (the “Fifth Amendment”) with NH Expansion Credit Fund Holdings LP (the “Agent”) and the noteholders party thereto (the “Holders”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000114036124011798/0001140361-24-011798-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.